Shona Hendry

Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials

Jan Hudecek, Leonie Voorwerk, Maartje van Seijen, Iris Nederlof, Michiel de Maaker, Jose van den Berg, Koen K van de Vijver, Karolina Sikorska, Sylvia Adams, Sandra Demaria, Giuseppe Viale, Torsten O Nielsen, Sunil S Badve, Stefan Michiels, William Fraser Symmans, Christos Sotiriou, David L Rimm, Stephen M Hewitt, Carsten Denkert, Sibylle Loibl, et al.

Journal article  |  2020  |  npj Breast Cancer

Stromal tumor-infiltrating lymphocytes (sTILs) are a potential predictive biomarker for immunotherapy response in metastatic tripl..

Correlation between percutaneous biopsy and final histopathology for retroperitoneal sarcoma: a single-centre study

Rebekah Young, Hayden Snow, Shona Hendry, Catherine Mitchell, John Slavin, Stephen Schlicht, Lumine Na, Michael S Hofman, David E Gyorki

Journal article  |  2020  |  ANZ Journal of Surgery

Adequate tumour cellularity is essential for accurate PD-L1 immunohistochemistry assessment on cytology cell-block specimens

Shona Hendry, David J Byrne, Michael Christie, Daniel P Steinfort, Louis B Irving, Carrie-Anne Wagner, Timothy Ellwood, Wendy A Cooper, Stephen B Fox

Journal article  |  2020  |  Cytopathology

OBJECTIVES: PD-L1 immunohistochemistry (IHC) is an essential predictive biomarker for patients with non-small cell lung cancer (NS..

CD8( ) tumor-infiltrating lymphocytes within the primary tumor of patients with synchronous de novo metastatic colorectal carcinoma do not track with survival

Rosemary Millen, Shona Hendry, Vignesh Narasimhan, Rebecca Abbott, Matthew Croxford, Peter Gibbs, Jeanne Tie, Hui-Li Wong, Ian Jones, Suzanne Kosmider, David Byrne, John Zalcberg, Stephen Fox, Jayesh Desai, Kumar Visvanathan, Robert G Ramsay, Ben Tran

Journal article  |  2020  |  Clinical and Translational Immunology

The Role of FDG - PET in Retroperitoneal Sarcomas - A Multicenter Retrospective Study

S Subramaniam, J Callahan, M Bressel, M Hofman, C Mitchell, S Hendry, FL Vissers, B van der Hiel, D Patel, WJ van Houdt, W Tseng, DE Gyorki

Conference Proceedings  |  2019  |  ANNALS OF SURGICAL ONCOLOGY

Treatment of patients with primary retroperitoneal sarcoma: predictors of outcome from an Australian specialist sarcoma centre

Hayden A Snow, Tatiana X Hitchen, Jessica Head, Alan Herschtal, Susie Bae, Sarat Chander, Julie Chu, Shona Hendry, Samuel Y Ngan, Jayesh Desai, Peter FM Choong, Michael Henderson, David E Gyorki

Journal article  |  2018  |  ANZ Journal of Surgery

Response to Editorial: The PD-L1 Immunohistochemistry Biomarker: Two Steps Forward, One Step Back?

Shona Hendry, Wendy A Cooper, Stephen B Fox

Journal article  |  2018  |  Journal of Thoracic Oncology

Prognostic Significance of PD-L1( ) and CD8( ) Immune Cells in HPV Oropharyngeal Squamous Cell Carcinoma

Benjamin Solomon, Richard J Young, Mathias Bressel, Damien Urban, Shona Hendry, Alesha Thai, Christopher Angel, Afaf Haddad, Marcin Kowanetz, Tsien Fua, June Corry, Stephen Fox, Danny Rischin

Journal article  |  2018  |  Cancer Immunology Research

Comparison of Four PD-L1 Immunohistochemical Assays in Lung Cancer

Shona Hendry, David J Byrne, Gavin M Wright, Richard J Young, Sue Sturrock, Wendy A Cooper, Stephen B Fox

Journal article  |  2018  |  Journal of Thoracic Oncology

Determinants of variability of five programmed death ligand-1 immunohistochemistry assays in non-small cell lung cancer samples

RA Soo, JSY Lim, BR Asuncion, Z Fazreen, MC Herrera, MFM Omar, NHD Phuong, JE Seet, B Amanuel, B Iacopetta, D Byrne, S Hendry, S Fox, R Soong

Journal article  |  2018  |  Oncotarget